Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.1mm RC, SLA? 12mm, TiZr, NTP: medical device reports filed with FDA

6,643 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

6,643
device reports naming the brand
0% of all MAUDE reports · about 973 a year
766
reports, 12 months to August 2026
985 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

6,643 medical device reports received by FDA name the brand "BL, ? 4.1mm RC, SLA? 12mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

766 reports arrived in the 12 months to August 2026, down 22% from 985 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (69.4%), loss of osseointegration (23.4%) and difficult to insert (1.1%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

094188Sep 2021: 83Oct 2021: 92Nov 2021: 74Dec 2021: 632022Jan 2022: 92Feb 2022: 53Mar 2022: 77Apr 2022: 72May 2022: 91Jun 2022: 61Jul 2022: 103Aug 2022: 96Sep 2022: 90Oct 2022: 74Nov 2022: 59Dec 2022: 802023Jan 2023: 99Feb 2023: 79Mar 2023: 65Apr 2023: 51May 2023: 64Jun 2023: 77Jul 2023: 61Aug 2023: 55Sep 2023: 53Oct 2023: 79Nov 2023: 72Dec 2023: 752024Jan 2024: 63Feb 2024: 61Mar 2024: 74Apr 2024: 96May 2024: 66Jun 2024: 74Jul 2024: 73Aug 2024: 65Sep 2024: 68Oct 2024: 146Nov 2024: 118Dec 2024: 812025Jan 2025: 81Feb 2025: 58Mar 2025: 81Apr 2025: 30May 2025: 0Jun 2025: 188Jul 2025: 66Aug 2025: 68Sep 2025: 46Oct 2025: 62Nov 2025: 54Dec 2025: 692026Jan 2026: 50Feb 2026: 60Mar 2026: 73Apr 2026: 65May 2026: 66Jun 2026: 85Jul 2026: 51Aug 2026: 85

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04939852019: 72120192020: 86220202021: 95920212022: 94820222023: 83020232024: 98520242025: 80320252026: 5352026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%6,643
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report88.9%5,907
Voluntary report0%0
User facility report0%0
Distributor report11.1%736
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,61069.4%62.8%
Loss of osseointegration1,55723.4%22.4%
Difficult to insertthe device was hard to insert731.1%0.4%
Fracturea broken bone520.8%1.6%
Separation failure130.2%0.1%
Unintended movement80.1%0%
Therapeutic or diagnostic output failure70.1%0%
Unstable60.1%0%
Activation, positioning or separation problem40.1%0%
Difficult to removethe device was hard to remove10%0%
Output problem10%0%
Positioning problem10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis2,09831.6%
Painpain, site not specified1,54823.3%
Tissue damage95914.4%
Inflammationinflammation6599.9%
Swelling/ edema5037.6%
Hemorrhage/blood loss/bleeding4516.8%
Fistula3174.8%
Abscessa collection of pus2724.1%
Hyperresponsive to stimuli1542.3%
Swellingswelling961.4%
Hypersensitivity/allergic reaction851.3%
Failure of implant510.8%
Inadequate osseointegration220.3%
Increased sensitivity190.3%
Numbnessnumbness170.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.1mm RC, SLA? 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports6,6433,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer88.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.1mm RC, SLA? 12mm, TiZr, NTP reports

How many FDA reports name BL, ? 4.1mm RC, SLA? 12mm, TiZr, NTP?

6,643 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 766 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (69.4%), loss of osseointegration (23.4%), difficult to insert (1.1%), fracture (0.8%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (88.9%) and distributor reports (11.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.1mm RC, SLA? 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.